A Greek Conversational Agent for Hematologic Malignancies: Usability and User Experience Assessment.

Journal: Studies in health technology and informatics
PMID:

Abstract

Enabling patients to actively document their health information significantly improves understanding of how therapies work, disease progression, and overall life quality affects for those living with chronic disorders such as hematologic malignancies. Advancements in artificial intelligence, particularly in areas such as natural language processing and speech recognition, have resulted in the development of interactive tools tailored for healthcare. This paper introduces an innovative conversational agent tailored to the Greek language. The design and deployment of this tool, which incorporates sentiment analysis, aims at gathering detailed family histories and symptom data from individuals diagnosed with hematologic malignancies. Furthermore, we discuss the preliminary findings from a feasibility study assessing the tool's effectiveness. Initial feedback on the user experience suggests a positive reception towards the agent's usability, highlighting its potential to enhance patient engagement in a clinical setting.

Authors

  • Maria E Chatzimina
    Dept. of Electrical and Computer Engineering, Hellenic Mediterranean University, Heraklion, Greece.
  • Helen A Papadaki
    Dept. of Hematology, School of Medicine University of Crete Heraklion, Greece.
  • Charalampos Pontikoglou
    Dept. of Hematology, School of Medicine University of Crete Heraklion, Greece.
  • Manolis Tsiknakis
    Computational BioMedicine Laboratory, FORTH-ICS, Heraklion, Crete, Greece.